
/
RSS Feed
Today we will be discussing the Moderna version of the COVID-19 vaccine, including the very good preliminary results from its Phase 3 trial.
Link:
COVID Vaccine Excitement Builds as Moderna Reports Positive Result
Sit back, relax, and unwind.
Today we will be discussing the Moderna version of the COVID-19 vaccine, including the very good preliminary results from its Phase 3 trial.
Link:
COVID Vaccine Excitement Builds as Moderna Reports Positive Result
Today’s episode, we’ll be examining the requirement for extremely cold temperatures for the Pfizer vaccine for COVID-19, and how making seemingly small assumptions early on in a project can really fundamentally change things later on.
Today I’ll be discussing the ramifications of a timeline where we get a useful COVID vaccine from Pfizer in the spring, and the hope that things in that timeline quickly go back to something resembling normalcy.